Osteoporosis International

, Volume 19, Issue 6, pp 787–792 | Cite as

Association of aromatase and estrogen receptor gene polymorphisms with hip fractures

  • C. Valero
  • J. L. Pérez-Castrillón
  • M. T. Zarrabeitia
  • J. L. Hernández
  • M. A. Alonso
  • J. del Pino-Montes
  • J. M. Olmos
  • J. González-Macías
  • J. A. RianchoEmail author
Original Article



Two polymorphisms of the aromatase and estrogen receptor genes appeared to interact to influence the risk of hip fractures in women.


Allelic variants of the aromatase gene have been associated with bone mineral density and vertebral fractures. Our objective was to analyze the relationship between two polymorphisms of the aromatase and estrogen receptor genes and hip fractures.


We studied 498 women with hip fractures and 356 controls. A C/G polymorphism of the aromatase gene and a T/C polymorphism of the estrogen receptor α gene were analyzed using Taqman assays. Aromatase gene expression was determined in 43 femoral neck samples by real-time RT-PCR.


There were no significant differences in the overall distribution of genotypes between the fracture and control groups. However, among women with a TT genotype of the estrogen receptor, the CC aromatase genotype was more frequent in women with fractures than in controls (39 vs. 23%, p = 0.009). Thus, women homozygous for T alleles of estrogen receptor and C alleles of aromatase were at increased risk of fracture (odds ratio 2.0; 95% confidence interval 1.2–3.4). The aromatase polymorphism was associated with RNA levels in bone tissue, which were three times lower in samples with a CC genotype (p = 0.009).


These common polymorphisms of the aromatase and estrogen receptor genes appear to interact, influencing the risk of hip fractures in women.


Aromatase Estrogen receptor Hip fractures Osteoporosis Polymorphisms 


  1. 1.
    Ralston SH, de Crombrugghe B (2006) Genetic regulation of bone mass and susceptibility to osteoporosis. Genes Dev 20:2492–2506CrossRefPubMedGoogle Scholar
  2. 2.
    Baldock PA, Eisman JA (2004) Genetic determinants of bone mass. Curr Opin Rheumatol 16:450–456CrossRefPubMedGoogle Scholar
  3. 3.
    Peacock M, Turner CH, Econs MJ, Foroud T (2002) Genetics of osteoporosis. Endocr Rev 23:303–326CrossRefPubMedGoogle Scholar
  4. 4.
    Riggs BL, Khosla S, Melton LJ III (2002) Sex steroids and the construction and conservation of adult skeleton. Endocr Rev 23:279–302CrossRefPubMedGoogle Scholar
  5. 5.
    Syed FS, Khosla S (2005) Mechanisms of sex steroid effects on bone. Biochem Biophys Res Commun 328:688–696CrossRefPubMedGoogle Scholar
  6. 6.
    Simpson ER (2000) Role of aromatase in sex steroid action. J Mol Endocrinol 25:1549–1556CrossRefGoogle Scholar
  7. 7.
    McCloskey E (2006) Effects of third-generation aromatase inhibitors on bone. Eur J Cancer 42:1044–1051CrossRefPubMedGoogle Scholar
  8. 8.
    Masi L, Becherini L, Gennari L et al (2001) Polymorphism of the aromatase gene in postmenopausal Italian women: distribution and correlation with bone mass and fracture risk. J Clin Endocrinol Metab 86:2263–2269PubMedGoogle Scholar
  9. 9.
    Somner J, McLellan S, Cheung J et al (2004) Polymorphisms in the P450 c17(17-hydroxylase/17,20-lyase) and P450 c19 (aromatase) genes: association with serum sex steroid concentrations and bone mineral density in postmenopausal women. J Clin Endocrinol Metab 89:344–351CrossRefPubMedGoogle Scholar
  10. 10.
    Zarrabeitia MT, Hernandez JL, Valero C et al (2004) A common polymorphism in the 5′-untranslated region of the aromatase gene influences bone mass and fracture risk. Eur J Endocrinol 150:699–704CrossRefPubMedGoogle Scholar
  11. 11.
    Riancho JA, Zarrabeitia MT, Valero C, Sanudo C, Mijares V, Gonzalez-Macias J (2006) A gene-to-gene interaction between aromatase and estrogen receptors influences bone mineral density. Eur J Endocrinol 155:53–59CrossRefPubMedGoogle Scholar
  12. 12.
    Riancho JA, Zarrabeitia MT, Valero C et al (2005) Aromatase gene and osteoporosis: relationship of ten polymorphic loci with bone mineral density. Bone 36:917–925CrossRefPubMedGoogle Scholar
  13. 13.
    Choi JY, Shin A, Park SK et al (2005) Genetic polymorphisms of OPG, RANK, and ESR1 and bone mineral density in Korean postmenopausal women. Calcif Tissue Int 77:152–159CrossRefPubMedGoogle Scholar
  14. 14.
    Gennari L, Merlotti D, De Paola V et al (2005) Estrogen receptor gene polymorphisms and the genetics of osteoporosis: a HuGE review. Am J Epidemiol 161:307–320CrossRefPubMedGoogle Scholar
  15. 15.
    Kobayashi N, Fujino T, Shirogane T et al (2002) Estrogen receptor alpha polymorphism as a genetic marker for bone loss, vertebral fractures and susceptibility to estrogen. Maturitas 41:193–201CrossRefPubMedGoogle Scholar
  16. 16.
    Nam HS, Shin MH, Kweon SS et al (2005) Association of estrogen receptor-alpha gene polymorphisms with bone mineral density in postmenopausal Korean women. J Bone Miner Metab 23:84–89CrossRefPubMedGoogle Scholar
  17. 17.
    Kjaergaard AD, Ellervik C, Tybjaerg-Hansen A (2007) Estrogen receptor alpha polymorphism and risk of cardiovascular disease, cancer, and hip fracture: cross-sectional, cohort, and case-control studies and a meta-analysis. Circulation 115:861–871CrossRefPubMedGoogle Scholar
  18. 18.
    Aerssens J, Dequeker J, Peeters J, Breemans S, Broos P, Boonen S (2000) Polymorphisms of the VDR, ER and COLIA1 genes and osteoporotic hip fracture in elderly postmenopausal women. Osteoporos Int 11:583–591CrossRefPubMedGoogle Scholar
  19. 19.
    Ioannidis JPA, Ralston SH, Bennett ST, Brandi ML, Grinberg D, Karassa FB et al (2004) Differential genetics effects of ESR1 gene polymorphisms on osteoporosis outcomes. JAMA 292:2105–2114CrossRefPubMedGoogle Scholar
  20. 20.
    Ioannidis JPA, Stavrou I, Trikalinos TA et al (2002) Association of polymorphisms of the estrogen receptor alpha gene with bone mineral density and fracture risk in women: a meta-analysis. J Bone Miner Res 17:2048–2060CrossRefPubMedGoogle Scholar
  21. 21.
    Riancho JA, Valero C, Naranjo A, Morales DJ, Sanudo C, Zarrabeitia MT (2007) Identification of an aromatase haplotype that is associated with gene expression and postmenopausal osteoporosis. J Clin Endocrinol Metab 92:660–665CrossRefPubMedGoogle Scholar
  22. 22.
    Haiman CA, Dossus L, Setiawan VW et al (2007) Genetic variation at the CYP19A1 locus predicts circulating estrogen levels but not breast cancer risk in postmenopausal women. Cancer Res 67:1893–1897CrossRefPubMedGoogle Scholar
  23. 23.
    Olson SH, Bandera EV, Orlow I (2007) Variants in estrogen biosynthesis genes, sex steroid hormone levels, and endometrial cancer: a HuGE review. Am J Epidemiol 165:235–245CrossRefPubMedGoogle Scholar
  24. 24.
    Dick IM, Devine A, Prince RL (2005) Association of an aromatase TTTA repeat polymorphism with circulating estrogen, bone structure, and biochemistry in older women. Am J Physiol Endocrinol Metab 288:E989–E995CrossRefPubMedGoogle Scholar
  25. 25.
    Xiong DH, Zhao LJ, Xiao P et al (2006) Robust and comprehensive analysis of 20 osteoporosis candidate genes by very high-density single-nucleotide polymorphism screen among 405 white nuclear families identified significant association and gene-gene interaction. J Bone Miner Res 21:1678–1695CrossRefPubMedPubMedCentralGoogle Scholar
  26. 26.
    Riancho JA (2007) Polymorphisms in the CYP19 gene that influence bone mineral density. Pharmacogenomics 8:339–352CrossRefPubMedGoogle Scholar
  27. 27.
    Herrington DM, Howard TD, Brosnihan KB et al (2002) Common estrogen receptor polymorphism augments effects of hormone replacement therapy on E-selectin but not C-reactive protein. Circulation 105:1879–1882CrossRefPubMedGoogle Scholar
  28. 28.
    Acha O, Hernandez JL, Penado S, Cano M, Riancho JA (2003) Factores de riesgo de ictus en pacientes de diferentes edades. Rev Clin Esp 203:189–192CrossRefPubMedGoogle Scholar
  29. 29.
    Cummings SR, Nevitt MC, Browner WS et al (1995) Risk factors for hip fracture in white women. N Engl J Med 332:767–773CrossRefPubMedGoogle Scholar
  30. 30.
    Kanis JA, Johansson H, Oden A et al (2004) A family history of fracture and fracture risk: a meta-analysis. Bone 35:1029–1037CrossRefPubMedGoogle Scholar
  31. 31.
    Michaelsson K, Melhus H, Ferm H, Ahlbom A, Pedersen NL (2005) Genetic liability to fractures in the elderly. Arch Intern Med 165:1825–1830CrossRefPubMedGoogle Scholar

Copyright information

© International Osteoporosis Foundation and National Osteoporosis Foundation 2007

Authors and Affiliations

  • C. Valero
    • 1
  • J. L. Pérez-Castrillón
    • 2
  • M. T. Zarrabeitia
    • 3
  • J. L. Hernández
    • 1
  • M. A. Alonso
    • 4
  • J. del Pino-Montes
    • 5
  • J. M. Olmos
    • 1
  • J. González-Macías
    • 1
  • J. A. Riancho
    • 1
    Email author
  1. 1.Department of Internal Medicine, Hospital U.M. ValdecillaUniversity of CantabriaSantanderSpain
  2. 2.Department of Internal Medicine, Hospital U. Río HortegaUniversity of ValladolidValladolidSpain
  3. 3.Unit of Legal MedicineUniversity of CantabriaSantanderSpain
  4. 4.Department of Traumatology, Hospital U.M. ValdecillaUniversity of CantabriaSantanderSpain
  5. 5.Department of Internal Medicine, Hospital U. Virgen de la VegaUniversity of SalamancaSalamancaSpain

Personalised recommendations